Journey Medical Corporation (DERM)

NASDAQ: DERM · IEX Real-Time Price · USD

5.46

-0.05 (-0.91%)

At close: Jul 19, 2024, 4:00 PM

5.44

-0.02 (-0.37%)

Pre-market: Jul 20, 2024, 9:28 AM EDT

Journey Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	80	79.18	73.67	63.13	44.53	34.92
Revenue Growth (YoY)	27.82%	7.48%	16.69%	41.78%	27.52%	-
Cost of Revenue	27.03	26.66	30.78	32.08	14.59	10.53
Gross Profit	52.97	52.52	42.89	31.05	29.94	24.39
Selling, General & Admin	39.04	43.91	59.47	39.83	22.09	19.13
Research & Development	13.39	7.54	10.94	16.56	0	0
Other Operating Expenses	3.14	3.14	0	9.54	0	0
Operating Expenses	55.57	54.59	70.41	65.93	22.09	19.13
Operating Income	-2.6	-2.07	-27.52	-34.88	7.85	5.26
Interest Expense / Income	1.6	1.7	2.02	7.03	0.7	0.26
Other Expense / Income	-0.26	-0.14	0.03	0.45	-	-
Pretax Income	-3.94	-3.63	-29.57	-42.36	7.15	5
Income Tax	0.22	0.22	0.06	1.63	1.87	1.38
Net Income	-4.16	-3.85	-29.63	-43.99	5.28	3.63
Net Income Growth	-	-	-	-	45.74%	-
Shares Outstanding (Basic)	20	18	18	10	9	9
Shares Outstanding (Diluted)	20	18	18	10	11	10
Shares Change	10.95%	4.00%	72.05%	-5.96%	7.55%	-
EPS (Basic)	-0.20	-0.21	-1.69	-4.32	0.58	0.40
EPS (Diluted)	-0.31	-0.21	-1.69	-4.32	0.49	0.36
EPS Growth	-	-	-	-	36.11%	-
Free Cash Flow	1.18	5.24	-13.53	-2.18	5.13	9.02
Free Cash Flow Per Share	0.06	0.29	-0.77	-0.21	0.56	0.99
Gross Margin	66.22%	66.33%	58.23%	49.18%	67.23%	69.84%
Operating Margin	-3.25%	-2.62%	-37.35%	-55.25%	17.63%	15.06%
Profit Margin	-5.20%	-4.87%	-40.22%	-69.68%	11.86%	10.38%
Free Cash Flow Margin	1.47%	6.62%	-18.37%	-3.45%	11.52%	25.82%
Effective Tax Rate	-	-	-	-	26.14%	27.56%
EBITDA	1.26	1.92	-23.18	-32.77	7.95	5.35
EBITDA Margin	1.57%	2.43%	-31.47%	-51.90%	17.85%	15.32%
Depreciation & Amortization	3.6	3.86	4.37	2.56	0.1	0.09
EBIT	-2.34	-1.93	-27.55	-35.33	7.85	5.26
EBIT Margin	-2.93%	-2.44%	-37.39%	-55.95%	17.63%	15.06%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).